A Randomised, Open-label, 3-period crossover study to compare the relative pulmonary bioavailability of fluticasone-propionate/formoterol BAI and pMDI in Healthy Volunteers
Latest Information Update: 15 Nov 2017
At a glance
- Drugs Formoterol/fluticasone propionate (Primary)
- Indications Asthma
- Focus Pharmacokinetics
- Sponsors Mundipharma Research
- 15 Nov 2017 New trial record